Somatic Systems, Inc. (PINKSHEETS: SMAS) announced that it has released its most recent financial reports, bringing its financial reporting status current on Pink Sheets. These releases exceed the standards for Pink Sheets' rating for Limited Information, removing the "Stop Sign" symbol from the company's Pink Sheets listing, and providing the company with the second highest rating for the Pink Sheets market.
The reports include the company's current first fiscal quarter and the previous fiscal year. Earnings were comparable with the previous year, showing the typical fluctuation per quarter due to yearly variations in the fiscal quarters in which the company collects tuition revenue for its Professional Training Program.
"We are pleased to report a fiscal stability during the worst economic times in decades," stated company CEO Steven Aronstein. "Furthermore, we are excited about the opportunities we have nurtured over the past year, such as pain treatment services for the US military, increased production and international distribution of our self-help products, and expansion of clinic and training operations... At a time when other companies are contracting or closing down altogether, we are facing record expansion opportunities."
The company filed its financial reports with Pink Sheets as part of its efforts to achieve full reporting status on the Pink Sheets to obtain the highest rating on Pink Sheets. This effort is also part of Somatic Systems' current efforts to complete full reporting status with the SEC and uplist the company to the OTC Bulletin Board stock exchange and higher.